Skip to content

A randomized controlled trial for Jiuwei Zhuhuang powder in the treatment of infantile cough

A randomized controlled trial for Jiuwei Zhuhuang powder in the treatment of infantile cough

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004840
Enrollment
Unknown
Registered
2020-10-27
Start date
2019-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cough

Interventions

Sponsors

The First Affiliated Hospital of Zhengzhou University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. The patient was diagnosed as a child with acute upper respiratory tract infection, and cough was the main symptom (>=2 points), and the onset time was within 48h; 2. syndrome differentiation for Tibetan medicine "qiang cai"; 3. Aged 2 to 14 years.

Exclusion criteria

Exclusion criteria: 1. Children with severe malnutrition, or accompanied by other serious systemic diseases such as cardiovascular, liver, kidney and hematopoietic system, children with mental disorders, and children allergic to this medicine; 2. Children with epstein-barrvirus (EBV) infection, mycoplasma infection, high risk of upper respiratory tract diseases and respiratory infectious diseases; 3. Children with bronchiolitis, bronchitis, pneumonia and other lower respiratory tract infections; 4. Children who have taken anti-cold or cough medicine (including western medicine and traditional Chinese medicine) after onset.

Design outcomes

Primary

MeasureTime frame
Cough;

Secondary

MeasureTime frame
Nasal congestion;Runny nose;Sneeze;Body temperature;adverse reactions;

Countries

China

Contacts

Public ContactPeng Shao
pengshaodh630@126.com+86 13838067954

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026